Verition Fund Management
LMDXW

Verition Fund Management’s LumiraDx Limited Warrant LMDXW Stock Holding History

Verition Fund Management’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,495
Closed -$2K – 2963
2022
Q3 		$2K Hold
14,495
– – ﹤0.01% 2996
2022
Q2 		$39K Hold
14,495
– – ﹤0.01% 2173
2022
Q1 		$12K Hold
14,495
– – ﹤0.01% 2643
2021
Q4 		$21K Hold
14,495
– – ﹤0.01% 2475
2021
Q3 		$17K Buy
+14,495
New +$16.8K ﹤0.01% 1832

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return

Verition Fund Management's LMDXW Position: Q4 2022 in Review

Verition Fund Management sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2022, closing a stake of 14,495 shares — an estimated $2K sold.

Verition Fund Management first reported a position in LMDXW in Q3 2021 and held it in 5 quarters. The position peaked at $39K in Q2 2022. 17 funds tracked by Wall St. Rank hold LMDXW as of Q4 2022.

  • Verition Fund Management reported no remaining LumiraDx Limited Warrant position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 14,495 LumiraDx Limited Warrant shares in Q4 2022, an estimated $2K.
  • Verition Fund Management first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 5 quarters.
  • Verition Fund Management's LumiraDx Limited Warrant position peaked at $39K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.